Composite Artificial Skin Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The composite artificial skin market is anticipated to grow at a CAGR of 5% during the forecast period (2022-2028). Composite artificial skin is defined as synthetically cultured skin that is used as an aseptically processed wound dressing composed of a bovine collagen matrix in which normal human allogeneic skin cells are cultured in two layers. Such skin is usually prepared from bovine collagen matrix, which is easily resorbed by the body and facilitates generation of new skin on the affected area. Reconstituted human epidermis, one artificial skin type, can be cultured as submerged epidermal equivalents. Such benefits offered by the regenerative artificial skin procedure are likely to augment the market growth during the forecast period.

Composite cultured skin is composed of human skin cells, which are derived from infant foreskin and placed on a porous collagen scaffold. Thus, it finds significant application in skin trauma related injuries such as accidents and burns. The global composite artificial skin market growth is also attributable to the growing demand for surgical procedures to restore skin on account of the incidence of accidental skin burns. For instance, as per the American Burn Association, 486,000 people received medical treatment for minor burns and 70,000 people were hospitalized for severe skin burn requiring acute care in the US, in 2015. Composite artificial skin covers and protects the wound and also promotes regeneration of natural skin.

Some key players operating in the market include Integra Life Sciences Corp., Smith & Nephew plc, and Organogenesis Holdings Inc., among others. The market players are focusing on several strategies such as mergers and acquisitions, partnerships, product launches, and collaborations, to increase their market share. For instance, in March 2019, Smith & Nephew plc declared that it has agreed to pay $660 million to acquire Osiris Therapeutics to enhance its presence in the regenerative medicine market. The addition of the Osiris Therapeutics will augment Smith & Nephew’s advanced wound management unit.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-

• By Type
• By Application

• Regions covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape:Integra Life Sciences Corp., Smith & Nephew plc, and Organogenesis Holdings Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

• Deviation from the pre-COVID-19 forecast
• Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Composite Artificial Skin Market Report by Segment

By Type

• Skin Graft
• Engineered Skin Material

By Application

• Hospitals
• Wound Care Centers
• Others